We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Vicotex

Download Mobile App




Abbott Sublicenses Lateral Flow Technology to Calypte

By HospiMedica staff writers
Posted on 23 Aug 2004
A sublicense for certain worldwide rights to patents relating to the design, manufacture, and sale of lateral-flow rapid diagnostic tests has been granted by Abbott Laboratories (Abbott Park, IL, USA) to Calypte Biomedical Corp. More...
(Pleasanton, CA, USA).

Under the terms of the agreement, Calypte was granted certain worldwide rights to use a family of patents known as the Guire/Swanson patents. The technology underlying these patents is fundamental to all lateral-flow rapid diagnostic tests. At the recent International AIDS Conference in Bangkok (Thailand), there was a focus on efforts to quickly identify people with HIV more quickly. Calypte plans to offer a menu of tests providing the HIV testing community with the option to choose from a complete line of rapid tests that can be used to test urine, oral fluid, and blood.

"We are pleased to have received a license to the Guire/Swanson patents from Abbott,” said Dr. Richard George, CEO of Calypte. "The technology covered by these patents is critical to the design of lateral-flow rapid tests. We believe it is one of the essential licenses that will provide us the freedom to manufacture and sell our emerging HIV rapid diagnostic tests in the U.S. and around the world.”




Related Links:
Abbott
Calypte

Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
Gold Member
Aspiration System
VACUSAFE
Hematology Consumables
Bioblood Devices
Platinum Member
Integrated Biochemical & Immunological System
Biolumi CX Solution X10+C10
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image Credit: Adobe Stock

Blood Biomarkers Help Assess Growth Risks During Steroid Treatment in Duchenne Muscular Dystrophy

Children with Duchenne muscular dystrophy (DMD) commonly receive long-term corticosteroids to slow disease progression, but these drugs can impair linear growth and weaken bone. Understanding how specific... Read more

Molecular Diagnostics

view channel
Image: The Xpert Hemorrhagic Fever Panel test runs on Cepheid’s GeneXpert Dx systems (Photo courtesy of Cepheid)

WHO Emergency Listing Supports Rapid Molecular Testing for Ebola Outbreak Response

The Democratic Republic of the Congo is confronting an Ebola Bundibugyo outbreak that the World Health Organization (WHO) designated a Public Health Emergency of International Concern on May 17, 2026.... Read more

Microbiology

view channel
Image Credit: Adobe Stock

Gut Microbiome Classifier Improves Colorectal Cancer Risk Stratification

Colorectal cancer remains a leading cause of cancer mortality, and current noninvasive screening methods still miss many precancerous lesions. Clinicians therefore need tools that improve risk stratification... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.